Cargando…
Activin A Causes Muscle Atrophy through MEF2C-Dependent Impaired Myogenesis
Activin A (ActA) is considered to play a major role in cancer-induced cachexia (CC). Indeed, circulating ActA levels are elevated and predict survival in patients with CC. However, the mechanisms by which ActA mediates CC development and in particular skeletal muscle (SM) atrophy in humans are not y...
Autores principales: | Loumaye, Audrey, Lause, Pascale, Zhong, Xiaoling, Zimmers, Teresa A., Bindels, Laure B., Thissen, Jean-Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997966/ https://www.ncbi.nlm.nih.gov/pubmed/35406681 http://dx.doi.org/10.3390/cells11071119 |
Ejemplares similares
-
Circulating Activin A predicts survival in cancer patients
por: Loumaye, Audrey, et al.
Publicado: (2017) -
p21-Activated Kinase 1 Is Permissive for the Skeletal Muscle Hypertrophy Induced by Myostatin Inhibition
por: Barbé, Caroline, et al.
Publicado: (2021) -
SAT670 Is Myostatin A Biomarker Of Skeletal Muscle Mass?
por: Orioli, Laura, et al.
Publicado: (2023) -
Marked Increased Production of Acute Phase Reactants by Skeletal Muscle during Cancer Cachexia
por: Massart, Isabelle S., et al.
Publicado: (2020) -
MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease
por: Nath, Samir R., et al.
Publicado: (2020)